Brief: iSpecimen Q3 Net Income USD -2.1 Million
Nov 02 (Reuters) - iSpecimen Q3 basic EPS USD -0.23. * Q3 revenue USD 2.8 million
Recent news on iSpecimen
See all newsBrief: iSpecimen Enters Asset Purchase Agreement With FoldLab AI On September 4
Brief: iSpecimen Appoints Shahin Behrozyan CEO, Katharyn Field To Leave Role
Brief: Ispecimen - Enters Settlement Agreement With Westpark Capital On August 6, 2026
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM